Clinical Trial Update: International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension [NA]

View source ↗

Summary

This update covers the international first-in-human study of Abbott's EnligHTN Generation 2 Renal Denervation system in patients with drug-resistant uncontrolle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• EnligHTN Generation 2 System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Hypertension, Renal Denervation | NA | Status: COMPLETED